News Sandoz's Enbrel biosimilar approved in US FDA approves first near-copy of inflammatory diseases drug.
Views & Analysis The biggest pharma stories of 2016 so far The top 10 pharma milestones of the year to date.
News Novartis drug effective in advanced MS Siponimod slowed disability progression in secondary progressive multiple sclerosis
News Decision to axe Afinitor 'confirms worst fears’ for Cancer D... NICE reviewing 'legacy drugs' to free up CDF funds
Cancer Novartis’ breast cancer drug LEEO11 gains breakthrough statu... Drug will challenge Pfizer's Ibrance
News Pharma faces pressure whoever wins Presidential race, warns ... Novartis chief warns on US pricing pressure
Patients Making direct-to-patient work, with Matt Wadyka Matt Wadyka, chief client strategy officer at Inizio Medical, spoke to pharmaphorum about the ins and outs of direct-to-patient programmes in pharma.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
